Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page was updated to revision v3.7.0, and several sections such as plain-language trial summary, results, sponsor references, and related regulatory/ keywords were removed from the listing. This changes how the study is presented and navigated.SummaryDifference21%

- Check38 days agoChange DetectedThe NIH grant/contract year 2016 is added to the study details, and the page revision is updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing v3.6.4. This appears to be a maintenance/version update rather than a change to study content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the page; visible study details appear unchanged.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page shows an updated revision to v3.6.3, indicating an update to the page framework.SummaryDifference0.0%

- Check102 days agoChange DetectedThe page header's revision label was updated from v3.6.0 to v3.6.2, indicating an update to the underlying platform. This change does not modify the study details or other user-facing information.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.